Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Taiwan Advanced Nanotech's FCF Margin % or its related term are showing as below:
ROCO:6797'
s FCF Margin % Range Over the Past 10 Years
Min: -150.6 Med: -10.62 Max: 33.48
Current: 6.77
During the past 9 years, the highest FCF Margin % of Taiwan Advanced Nanotech was 33.48%. The lowest was -150.60%. And the median was -10.62%.
ROCO:6797's FCF Margin % is ranked better than 67.16% of 813
companies
in the Medical Devices & Instruments industry
Industry Median: -0.71
vs ROCO:6797: 6.77
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6797 vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Taiwan Advanced Nanotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiwan Advanced Nanotech FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Taiwan Advanced Nanotech's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Taiwan Advanced Nanotech's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taiwan Advanced Nanotech (ROCO:6797) has a FCF Margin % of -4.30% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Taiwan Advanced Nanotech and its competitors. According to the industry distribution chart, Taiwan Advanced Nanotech ranks #267 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 32.8%.
Is Taiwan Advanced Nanotech's FCF Margin % too high?
Taiwan Advanced Nanotech's current FCF Margin % is -4.30%. Based on the distribution chart, Taiwan Advanced Nanotech ranks #267 out of 813 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Taiwan Advanced Nanotech has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Taiwan Advanced Nanotech's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Taiwan Advanced Nanotech ranks #267 out of 813 companies for FCF Margin %. This puts Taiwan Advanced Nanotech in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Taiwan Advanced Nanotech and its competitors. Taiwan Advanced Nanotech's current FCF Margin % is -4.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiwan Advanced Nanotech stock overvalued right now?
Based on GuruFocus' analysis, Taiwan Advanced Nanotech (ROCO:6797) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$16.43, compared to a current price of NT$12.00 — trading 27% below its estimated fair value. The current FCF Margin % is -4.30%. Taiwan Advanced Nanotech's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Taiwan Advanced Nanotech (ROCO:6797), the current FCF Margin % is -4.30% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiwan Advanced Nanotech (ROCO:6797) Overvalued in 2026?
Based on GuruFocus' analysis, Taiwan Advanced Nanotech stock appears to be undervalued.
The current stock price of NT$12.00 is trading 27% below its estimated GF Value™ of NT$16.43.
GuruFocus considers Taiwan Advanced Nanotech to be Modestly Undervalued.
Key valuation signals for ROCO:6797:
FCF Margin %: -4.30%
GF Value™: NT$16.43 vs. price of NT$12.00 (27% below fair value)
No single metric tells the full story. See the ROCO:6797 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiwan Advanced Nanotech Inc is engaged in development and manufacturing of various functional nanoparticles and automated nucleic acid extraction machines and trading related businesses. With expertise in automation, buffer optimization and modification of magnetic beads, it focuses on offering customer convenient and practical solutions to advance research, life science and molecular diagnostics. It offers various products to meet the requirements of customers. The company's products include Automated Extraction Instruments; Reagent Kit; Mag Nanoparticles; and Consumables.
60GF Score
Get the complete analysis for ROCO:6797
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6797 has been successfully added to your 
